Nicole Labrosse

Affiliations

  • Svp, Chief Financial Officer at Halozyme Therapeutics Inc. (HALO), 2025-02-24
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $54.25 992 $53,818.98 15,480 2024-07-22 Filing
HALO $53.85 4,008 $215,842.82 15,480 2024-07-22 Filing
HALO $52.04 10,000 $520,400.00 15,480 2024-06-28 Filing
HALO $51.93 10,000 $519,340.00 15,480 2024-06-27 Filing
HALO $51.82 10,000 $518,200.00 15,480 2024-06-26 Filing